To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.
Clinical trial NCT01011283 · TERMINATED
Trial details
- NCT number
- NCT01011283
- Sponsor
- Eisai Inc.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-01-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.